8K-Dean Schauer

0001445305-13-001672.txt : 20130723 0001445305-13-001672.hdr.sgml : 20130723 20130723145321 ACCESSION NUMBER: 0001445305-13-001672 CONFORMED SUBMISSION TYPE: 8-K PUBLIC DOCUMENT COUNT: 2 CONFORMED PERIOD OF REPORT: 20130723 ITEM INFORMATION: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers ITEM INFORMATION: Financial Statements and Exhibits FILED AS OF DATE: 20130723 DATE AS OF CHANGE: 20130723 FILER: COMPANY DATA: COMPANY CONFORMED NAME: ACCELLENT INC CENTRAL INDEX KEY: 0001342505 STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841] IRS NUMBER: 000000000 FILING VALUES: FORM TYPE: 8-K SEC ACT: 1934 Act SEC FILE NUMBER: 333-130470 FILM NUMBER: 13981199 BUSINESS ADDRESS: STREET 1: 200 WEST 7TH AVE CITY: COLLEGEVILL STATE: PA ZIP: 19426 BUSINESS PHONE: 866-899-1392 MAIL ADDRESS: STREET 1: 200 WEST 7TH AVE CITY: COLLEGEVILL STATE: PA ZIP: 19426 8-K 1 a8k-deanschauer.htm ACCELLENT INC. 8-K 8K-Dean Schauer

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 8-K

CURRENT REPORT

Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

Date of Report (Date of earliest event reported): July 19, 2013

ACCELLENT INC.

(Exact name of registrant as specified in its charter)



Maryland	333-130470	84-1507827
(State or other jurisdiction of incorporation)	(Commission File Number)	(IRS Employer Identification Number)



100 Fordham Road Wilmington, Massachusetts		01887
(Address of principal executive offices)		(Zip Code)

(978) 570-6900

(Registrant's telephone number, including area code)

Not Applicable

(Former name or former address, if changed since last report)

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):

o Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

o Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

o Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 240.14d-2(b))

o Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.

(b) On July 19, 2013, Dean Schauer notified Accellent Inc. (the “Company”) that he will resign from his position as the Company's Executive Vice President, General Manager, Cardio & Vascular Group, effective August 16, 2013. A comprehensive search is underway to identify and hire a replacement. Until a replacement is found, Donald J. Spence, the Company's Chairman and Chief Executive Officer, will serve as interim General Manager of the Cardio & Vascular Group.

A copy of the Company's press release announcing Mr. Schauer's resignation is attached to this current report as Exhibit 99.1 and is incorporated by reference herein.

Item 9.01 Exhibits.

(d) Exhibits

Exhibit No. Description



99.1	Press release, dated July 23, 2013, announcing the resignation of Dean Schauer from his position as the Company's Executive Vice President, General Manager, Cardio & Vascular Group.

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.



Date: July 23, 2013	ACCELLENT INC.

	By:	/s/ Jeremy A. Friedman
		Name: Jeremy A. Friedman Title: Chief Financial Officer

EXHIBIT INDEX



Exhibit No.		Description
99.1		Press release, dated July 23, 2013, announcing the resignation of Dean Schauer from his position as the Company's Executive Vice President, General Manager, Cardio & Vascular Group.

EX-99.1 2 a8k-deanschauerexhibit.htm EXHIBIT 99.1 8K-Dean Schauer Exhibit

Investor Contact:

Jeremy A. Friedman

Executive Vice President & Chief Financial Officer

(978)570-6900

jeremy.friedman@accellent.com

For Immediate Release

Dean Schauer, Executive Vice President, Cardio & Vascular Group, Announces Resignation

Wilmington, MA (July 23, 2013) - Accellent Inc. (the “Company” or “Accellent”), a leading provider of outsourced precision manufacturing and engineering services to the medical device industry, announced today that effective August 16, 2013, Dean Schauer is leaving the Company. Mr. Schauer has accepted an opportunity to become the President and Chief Executive Officer of a manufacturing and materials company located in California. A comprehensive search is underway to identify and hire a replacement for Mr. Schauer. Until a replacement is found, Donald J. Spence, the Company's Chairman and Chief Executive Officer, will serve as interim General Manager of the Cardio & Vascular Group.

“I have made the very difficult decision to depart Accellent in pursuit of an alternate opportunity,” Mr. Schauer commented. “I cannot express enough my gratitude and appreciation for my time at Accellent. Accellent's people are exceptionally talented and dedicated, and I have been greatly privileged to work with them. I am proud of what we have accomplished together, and I am confident that the Company will continue to succeed.”

Donald J. Spence, Accellent's Chairman and Chief Executive Officer stated, “On behalf of Accellent's Board of Directors, the Senior Leadership Team and all of Accellent, I would like to sincerely thank Dean for his thirteen years of service to the Company. Dean has been an outstanding contributor across a variety of leadership roles at Accellent during his tenure. We wish Dean well in his new position.”

About Accellent

Accellent, Inc. provides fully integrated, outsourced manufacturing and engineering services to the medical device industry in the cardiology, endoscopy and orthopaedic markets. Accellent has broad capabilities in design and engineering services, precision component fabrication, finished device assembly and complete supply chain management. These capabilities enhance customers' speed to market and return on investment by allowing companies to refocus internal resources efficiently. For more information please visit www.accellent.com.

Forward-Looking Statements

This press release includes “forward looking statements” within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Act of 1934, as amended. All statements included herein, other than statements of historical fact, may constitute forward-looking statements. Although the Company believes that the expectations reflected in such forward-looking statements are reasonable, it can give no assurance that such expectations will prove to be correct. Important factors that could cause actual results to differ materially from the Company's expectations are disclosed in the risk factors contained in the Company's Form 10-K for the year ended December 31, 2012 filed with the Securities and Exchange Commission on April 1, 2013. All forward-looking statements are expressly qualified in their entirety by such risk factors.